Nature/Aventis Horizon Symposium: Understanding the RNAissance
News Pointer: RNAi Horizon Symposium Highlights Nature/Aventis Horizon Symposium: Understanding the RNAissance
ALL NEWS
6538 RESULTS
Sort By:
- Most Recent
- Most Commented
News Pointer: RNAi Horizon Symposium Highlights
Enjoy an online summary of a <a href="http://www.nature.com/horizon/rna/index.html">Nature/Aventis Horizon Symposium</a> held last month in Maine...
Is SOD's Contribution to Lou Gehrig’s Disease Unfolding?
Mutations in the enzyme Cu/Zn superoxide dismutase (SOD) have been linked to about 20 percent of familial cases of amyotrophic lateral sclerosis (ALS), but there is no explanation yet for how the mutations contribute to ALS pathology...
Naproxen/Rofecoxib Trial Results Published
Both selective (COX-2 inhibitor, rofecoxib) and nonselective (COX-1/COX-2 inhibitor, naproxen) nonsteroidal antiinflammatory drugs (NSAIDs) fail to slow the cognitive decline associated with Alzheimer's disease (AD)...
Adult Neurogenesis in the "Black Substance"
Dopaminergic neurons in the mouse substantia nigra are replenished throughout the life of the animal, according to a report in the June 2 early online edition of PNAS...
Antibodies Found That Specifically Target Infectious Prions
Antibodies can be raised that specifically target misfolded prion proteins, leaving native proteins free to carry on their normal functions. This is the conclusion of a paper which appeared in yesterday's Nature Medicine online...
Immortality Gene in Embryonic Stem Cells Is Identified
Embryonic stem (ES) cells have the ability to divide ad infinitum. In today's Cell, two independent research groups report that a key to this "eternal youth" is the protein Nanog, which appears essential not only for cellular self-renewal, but also for...
International Conference on Alzheimer's & Parkinson's Diseases 2003
Notes from International AD/PD Conference 2003 in Seville International Conference on Alzheimer's & Parkinson's Diseases 2003
Dementia Risk Increases, at Least in Those Who Start Hormone Therapy Late
In sharp contrast to prevailing hypotheses, taking combination hormone replacement actually doubles a woman’s risk of developing dementia, including Alzheimer's disease, when the therapy is begun at age 65 or older...
Notes from International AD/PD Conference 2003 in Seville
Organized by Israel Hanin, Abraham Fisher, and Ramon Cacabelos, the 6th International Conference on Alzheimer’s and Parkinson’s Diseases was a great success. The number of registered participants reached over 1,200...
That Should Have Worked! Where to Publish? Try the New Journal of Negative Results
Launched by BioMed Central last fall, peer-reviewed, and indexed by PubMed, this free online publication seeks to fill a gap well-known to any researcher who has tried to publish such data in conventional scientific journals...
Lithium Hinders Aβ Generation, Buffing Up GSK as Drug Target
The widely used psychiatric drug lithium, and other agents that inhibit glycogen synthase kinase-3 (GSK3), have been mentioned as possible Alzheimer's disease therapies for some time, primarily because GSK3 is one of several kinases known to phosphorylate tau...
Alzheimer’s Vaccine: In Some Patients, at Least, It Might Just Work
After a tough year, during which believers in immunotherapy for Alzheimer’s disease have had to fend off vociferous criticism, the news now appears to pick up...
Aiding and Abetting, Hyperactive CDK5 Gives Mouse Tangles
Despite its long and distinguished history in Alzheimer’s research, the microtubule-stabilizing protein tau still poses many a riddle to scientists. They do know that excessive phosphorylation of tau somehow figures in neurodegeneration...
Insulin/Heat Shock Responses Compete to Control Aging and Polyglutamine Aggregation
Back-to-back papers in today’s Science shed new light on the role that insulin and heat shock proteins may play in the aging process...
Current Filters
No filters selected